Immuron

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. 

CEO
Steven Lydeamore
CEOSteven Lydeamore
Employees
—
Employees—
Headquarters
Blackburn, Victoria (VIC)
HeadquartersBlackburn, Victoria (VIC)
Founded
1994
Founded1994
Employees
—
Employees—

IMRN Key Statistics

Market cap
8.01M
Market cap8.01M
Price-Earnings ratio
-2.57
Price-Earnings ratio-2.57
Dividend yield
—
Dividend yield—
Average volume
20.83K
Average volume20.83K
High today
—
High today—
Low today
—
Low today—
Open price
$0.84
Open price$0.84
Volume
0.00
Volume0.00
52 Week high
$1.99
52 Week high$1.99
52 Week low
$0.6765
52 Week low$0.6765

IMRN News

TipRanks 23h
Immuron Publishes CEO Address and Annual General Meeting Results

An announcement from Immuron ( (IMRN) ) is now available. On November 18, 2026, Immuron published ASX announcements titled “CEO Address” and “Results of Annual...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.